Prosecution Insights
Prosecution Insights
13 pending office actions • 7 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (23%) |
| §112 only | 2 (15%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 6 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LALONDE, ALEXANDRA ELIZABETH | 2 | 70.8% | +33.8% |
| SHIN, DANA H | 1 | 27.0% | +27.4% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| MEDWAY, SCOTT J | 1 | 67.0% | +23.2% |
| VU, JAKE MINH | 1 | 40.7% | +27.6% |
| CHERNYSHEV, OLGA N | 1 | 54.5% | +34.2% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| PETERS, ALEC JON | 1 | 67.5% | +56.0% |
| LEWIS, PATRICK T | 1 | 74.2% | +14.2% |
| KIM, YUNSOO | 1 | 65.8% | +34.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | SHOSTAK, ANDREY | 118d overdue |
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | — |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | AEDER, SEAN E | — |
| 18196506 | IMPLANTABLE MEDICAL DEVICE AND SYSTEM | LALONDE, ALEXANDRA ELIZABETH | — |
| 18036459 | OLIGONUCLEOTIDES, REAGENTS, AND PREPARATION THEREOF | LEWIS, PATRICK T | — |
| 18300339 | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES | KIM, YUNSOO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | — |
| 18837245 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — |
| 18397190 | METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | VU, JAKE MINH | — |
| 18567674 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHERNYSHEV, OLGA N | — |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | AEDER, SEAN E | — |
| 18038911 | METHODS OF TREATING CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS | PETERS, ALEC JON | — |
| 18196506 | IMPLANTABLE MEDICAL DEVICE AND SYSTEM | LALONDE, ALEXANDRA ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1641 | 2 |
| 3783 | 2 |
| 1635 | 1 |
| 1642 | 1 |
| 1691 | 1 |
| 1628 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172111 | METHODS OF TREATING OR PREVENTING SPINAL MUSCULAR ATROPHY | SHIN, DANA H | 1635 | §103DP | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18837245 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | WHITE, DAWANNA SHAR-DAY | — | §112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18765894 | MEDICAL DEVICE HAVING NON-FILTERED CSF WITHDRAWAL PATHWAY | MEDWAY, SCOTT J | — | §102§103Other | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18397190 | METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | VU, JAKE MINH | — | §112Other | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18567674 | METHODS FOR TREATING ALZHEIMER'S DISEASE | CHERNYSHEV, OLGA N | — | §103 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | AEDER, SEAN E | 1642 | §102§103§112 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18038911 | METHODS OF TREATING CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS | PETERS, ALEC JON | 1641 | §103DPOther | Non-Final OA | — | Pending | May 25, 2023 |
| 18196506 | IMPLANTABLE MEDICAL DEVICE AND SYSTEM | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18036459 | OLIGONUCLEOTIDES, REAGENTS, AND PREPARATION THEREOF | LEWIS, PATRICK T | 1691 | §102§112 | Non-Final OA | — | Pending | May 11, 2023 |
| 18300339 | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES | KIM, YUNSOO | 1641 | §103§112 | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18021643 | METHODS FOR TREATING REMITTING MULTIPLE SCLEROSIS | CORNET, JEAN P | 1628 | §103Other | Non-Final OA | 49d overdue | Pending | Feb 16, 2023 |
| 18070029 | IMPLANTABLE INTRAVENTRICULAR SAMPLING AND INFUSION ACCESS DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103 | Non-Final OA | — | Pending | Nov 28, 2022 |
| 17380694 | MONITORING BASED ON CONTINUOUS INTRACRANIAL EEG ACTIVITY | SHOSTAK, ANDREY | 3791 | §103§112 | Non-Final OA | 118d overdue | Pending | Jul 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial